✦ LIBER ✦

Reversible suppression of nitric oxide system in essential hypertension

✍ Scribed by M. Chandra; D. R. Maurya; S. Kumar; H. Basara; A. Ghatak; B. L. Tekwani; G. Kaur; M. K. Misra

Publisher: Association of Clinical Biochemistry of India
Year: 2003
Tongue: English
Weight: 280 KB
Volume: 18
Category: Article
ISSN: 0970-1915
DOI: 10.1007/bf02867381

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nitric oxide in systemic and pulmonary h

Nitric oxide in systemic and pulmonary hypertension

✍ Hsing I. Chen; Cheng-Tao Hu; Chia-Yen Wu; David Wang 📂 Article 📅 1997 🏛 BioMed Central 🌐 English ⚖ 793 KB

Chromosome 17 and the inducible nitric o

Chromosome 17 and the inducible nitric oxide synthase gene in human essential hypertension

✍ Sue Rutherford; Matthew P. Johnson; Robert P. Curtain; Lyn R. Griffiths 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 74 KB

Nitric oxide suppression reversibly atte

Nitric oxide suppression reversibly attenuates mitochondrial dysfunction and cholestasis in endotoxemic rat liver

✍ Masaya Shiomi; Yoshiyuki Wakabayashi; Tsuyoshi Sano; Yuichi Shinoda; Yuji Nimura 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

Management of pulmonary hypertension in

Management of pulmonary hypertension in congenital diaphragmatic hernia: nitric oxide with prostaglandin-E1 versus nitric oxide alone

✍ Satoko Shiyanagi; Tadaharu Okazaki; Hiromichi Shoji; Toshiaki Shimizu; Toshitaka 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 183 KB

Nitric Oxide in the Evaluation of Congen

Nitric Oxide in the Evaluation of Congenital Heart Disease with Pulmonary Hypertension: Factors Related to Nitric Oxide Response

✍ B.C. Cannon; T.F. Feltes; J. Kennard Fraley; R.G. Grifka; E.M. Riddle; J.P. Kova 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 170 KB

Increased angiogenesis in portal hyperte

Increased angiogenesis in portal hypertensive rats: Role of nitric oxide

✍ Lazar T. Sumanovski; Edouard Battegay; Michael Stumm; Maaike van der Kooij; Corn 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Systemic and especially splanchnic arterial vasodilation accompany chronic portal hypertension. Different soluble mediators causing this vasodilation have been proposed, the strongest evidence being for nitric oxide (NO). No data exist if structural vascular changes may partly account for this vasod